Medical Devices company, Sterling, undergoes recapitalization and merges with RBC Medical Innovations.
In a significant move, Sterling Medical Devices and RBC Medical Innovations have officially merged on February 1, 2023. This strategic combination aims to expand Sterling Medical Devices' capabilities, offering a broader range of advanced medical solutions to meet diverse and evolving healthcare needs.
**Expanded Capabilities**
The merger brings together Sterling's existing medical device manufacturing strengths with RBC's cutting-edge technology innovations. This integration enables the combined company to develop more sophisticated, intelligent medical devices that enhance clinical outcomes. The expanded portfolio likely includes improved product design, streamlined operations, and smarter solutions across various medical applications.
**Benefits to Customers and Market Demands**
Customers gain access to a more comprehensive range of advanced medical devices tailored to meet specific clinical needs. The merger supports accelerated innovation, allowing faster development and deployment of new products. Enhanced operational efficiencies and intelligent solutions help healthcare providers improve patient care and optimize resource utilization. The combined strengths position Sterling Medical Devices to better respond to increasing market demands for modern, reliable, and effective medical technologies.
RBC Founder Carl Mayer will join the Board of Directors, while David Montecalvo has been appointed as the Chief Executive Officer of the combined company. Montecalvo, with over 35 years of experience in the Med Tech industry, including executive level positions at Medtronic and West Pharmaceutical Services, will lead the company towards its new vision.
Trevor Wahlbrink, partner at Ampersand Capital Partners, is enthusiastic about the company created following the combination of Sterling and RBC. Ampersand Capital Partners, a middle market private equity firm with $3 billion of assets under management dedicated to growth-oriented investments in the healthcare sector, led the transaction. The firm has offices in Boston, MA and Amsterdam, Netherlands, and leverages a unique blend of private equity and operating experience to build value and drive superior long-term performance.
For more information about Sterling Medical Devices, visit www.sterlingmedicaldevices.com. For more information about RBC Medical Innovations, visit www.rbccorp.com. Sterling Founder Dan Sterling will remain on the senior leadership team and continue as Board Director. The partnership is a win-win for current and prospective customers, providing a full outsourced solution for medical device innovation.
This merger enables Sterling Medical Devices to deliver greater value through innovation and expanded product offerings, benefiting both customers and addressing broader healthcare market trends.
- The merger of Sterling Medical Devices and RBC Medical Innovations, driven by their combined expertise in medical devices and technology, facilitates the development of more advanced, intelligent medical devices that can improve clinical outcomes.
- The strategic combination positions Sterling Medical Devices to better respond to market demands for modern, reliable, and effective medical technologies, offering a full outsourced solution for medical device innovation that addresses broader healthcare trends.
